Sunshine Biopharma (SBFM) Liabilities from Discontinued Operations (2018 - 2019)
Sunshine Biopharma's (SBFM) quarterly Liabilities from Discontinued Operations came in at 103732.0 in Q2 2019, little changed on a QoQ basis from 103732.0 in Q1 2019.
Sunshine Biopharma (SBFM) Liabilities from Discontinued Operations (2018 - 2019) Analysis & Trends
Sunshine Biopharma (SBFM) has 2 years of Liabilities from Discontinued Operations data on file, last reported at 103732.0 in Q2 2019.
- Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 103732.0 in Q2 2019, while the trailing twelve-month figure through Jun 2019 was 103732.0 (changed N/A YoY) and the FY2018 annual result came in at 103732.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations held at 103732.0 in Q2 2019, from 103732.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 103732.0 in Q4 2018 to a low of 103732.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Sunshine Biopharma | 1.60 Mn | -12.15 Mn | 2.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 103,732.00 |
| Jun 30, 2019 | 103,732.00 |
| Mar 31, 2019 | 103,732.00 |
| Mar 31, 2019 | 103,732.00 |
| Dec 31, 2018 | 103,732.00 |
| Dec 31, 2018 | 103,732.00 |